Literature DB >> 6604523

Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.

T Nilsson, I Sjöholm, B Wiman.   

Abstract

The reaction between complement factor C1s and C1-esterase inhibitor has been investigated by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, N-terminal amino acid analysis and c.d. studies. It is confirmed that a very stable stoichiometric 1:1 complex with a molecular weight of about 180000 is formed, involving the light chain of C1s. On the sodium dodecyl sulphate/polyacrylamide gels a small peptide with a molecular weight of about 5000 can be seen, which may be released from the C-terminal portion of the inhibitor moiety in a manner analogous to that occurring in other similar proteinase-inhibitor reactions. By N-terminal amino acid analysis, a newly formed threonine residue is found in the complex, suggesting that the inhibitor peptide chain is cleaved in the complex between C1s and C1-esterase inhibitor. The stabilizing bond may therefore be an ester bond. C.d. studies of the native C1-esterase inhibitor indicated the presence of about 38% alpha-helix, about 24% beta-structure and about 38% unordered structure. By gradual cleavage of the disulphide bridges under non-denaturating conditions, gradual changes in the c.d. spectra occurred, suggesting loss of ordered secondary structures. The c.d. spectra of the complex between C1s and C1-esterase inhibitor indicate that tryptophan residues are affected by the complex-formation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604523      PMCID: PMC1152176          DOI: 10.1042/bj2130617

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  C1 inactivator.

Authors:  P C Harpel
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

3.  Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.

Authors:  Y H Chen; J T Yang; K H Chau
Journal:  Biochemistry       Date:  1974-07-30       Impact factor: 3.162

4.  Contribution of tyrosine to circular dichroism changes accompanying neurophysin-hormone interaction.

Authors:  E Breslow; J Weis
Journal:  Biochemistry       Date:  1972-08-29       Impact factor: 3.162

5.  Near-ultraviolet absorption bands of tryptophan. Studies using horseradish peroxidase isoenzymes, bovine and horse heart cytochrome c, and N-stearyl-L-tryptophan n-hexyl ester.

Authors:  E H Strickland; J Horwitz; E Kay; L M Shannon; M Wilchek; C Billups
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

6.  Analysis of the vibrational structure in the near-ultraviolet circular dichroism and absorption spectra of tyrosine derivatives and ribonuclease-A at 77 degrees K.

Authors:  J Horwitz; E H Strickland; C Billups
Journal:  J Am Chem Soc       Date:  1970-04-08       Impact factor: 15.419

7.  Fine structure in the near-ultraviolet circular dichroism and absorption spectra of tryptophan derivatives and chymotrypsinogen A at 77 degrees K.

Authors:  E H Strickland; J Horwitz; C Billups
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

8.  Studies on the precursor form of the first component of complement--I. Isolation of the proenzyme forms of Clr and Cls.

Authors:  R M Chapuis; H Isliker; S N Assimeh
Journal:  Immunochemistry       Date:  1977-05

9.  Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.

Authors:  P C Harpel; N R Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

10.  Near-ultraviolet tyrosyl circular dichroism of pig insulin monomers, dimers, and hexamers. Dipole-dipole coupling calculations in the monopole approximation.

Authors:  E H Strickland; D Mercola
Journal:  Biochemistry       Date:  1976-08-24       Impact factor: 3.162

View more
  7 in total

1.  Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.

Authors:  M H Prandini; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

2.  The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

Authors:  T L Lindahl; P I Ohlsson; B Wiman
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

3.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Authors:  B L Zuraw; J G Curd
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 4.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

5.  Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.

Authors:  J Jackson; R B Sim; K Whaley; C Feighery
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis.

Authors:  T Nilsson; J Carlsson; G Sundqvist
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.